Pavmed Inc Stock Performance

PAVM Stock  USD 0.75  0.02  2.60%   
On a scale of 0 to 100, PAVmed holds a performance score of 6. The firm holds a Beta of 1.82, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PAVmed will likely underperform. Please check PAVmed's downside variance, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether PAVmed's historical price patterns will revert.

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, PAVmed displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:15
Last Split Date
2023-12-07
1
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
12/23/2024
2
Disposition of 12450 shares by Aklog Lishan of PAVmed at 1.6 subject to Rule 16b-3
01/02/2025
3
Lucid Diagnostics Achieves Record-Breaking Quarter with 84 percent Surge in EsoGuard DNA Test Volume - StockTitan
01/13/2025
4
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science Diagnostic Tools Conference
02/06/2025
5
PAVmed and Subsidiary Veris Health Complete Private Placement Financing
02/24/2025
6
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025
03/10/2025
7
Acquisition by Deguzman Brian J. of 50000 shares of PAVmed at 1.59 subject to Rule 16b-3
03/11/2025
8
Insider Trading
03/14/2025
Begin Period Cash Flow39.7 M
  

PAVmed Relative Risk vs. Return Landscape

If you would invest  61.00  in PAVmed Inc on December 19, 2024 and sell it today you would earn a total of  14.00  from holding PAVmed Inc or generate 22.95% return on investment over 90 days. PAVmed Inc is currently generating 0.494% in daily expected returns and assumes 5.6452% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than PAVmed, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days PAVmed is expected to generate 6.57 times more return on investment than the market. However, the company is 6.57 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.01 per unit of risk.

PAVmed Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for PAVmed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PAVmed Inc, and traders can use it to determine the average amount a PAVmed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0875

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsPAVM
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.65
  actual daily
50
50% of assets are less volatile

Expected Return

 0.49
  actual daily
9
91% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
6
94% of assets perform better
Based on monthly moving average PAVmed is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PAVmed by adding it to a well-diversified portfolio.

PAVmed Fundamentals Growth

PAVmed Stock prices reflect investors' perceptions of the future prospects and financial health of PAVmed, and PAVmed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PAVmed Stock performance.

About PAVmed Performance

By examining PAVmed's fundamental ratios, stakeholders can obtain critical insights into PAVmed's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that PAVmed is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 35.24  33.48 
Return On Tangible Assets(1.82)(1.91)
Return On Capital Employed 2.94  2.79 
Return On Assets(1.74)(1.83)
Return On Equity 1.37  2.44 

Things to note about PAVmed Inc performance evaluation

Checking the ongoing alerts about PAVmed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PAVmed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
PAVmed Inc had very high historical volatility over the last 90 days
PAVmed Inc has some characteristics of a very speculative penny stock
PAVmed Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 2.45 M. Net Loss for the year was (64.17 M) with loss before overhead, payroll, taxes, and interest of (2.37 M).
PAVmed Inc currently holds about 68.47 M in cash with (52.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
PAVmed Inc has a frail financial position based on the latest SEC disclosures
Roughly 29.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Insider Trading
Evaluating PAVmed's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate PAVmed's stock performance include:
  • Analyzing PAVmed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PAVmed's stock is overvalued or undervalued compared to its peers.
  • Examining PAVmed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating PAVmed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PAVmed's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of PAVmed's stock. These opinions can provide insight into PAVmed's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating PAVmed's stock performance is not an exact science, and many factors can impact PAVmed's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.14)
Revenue Per Share
0.45
Quarterly Revenue Growth
0.259
Return On Assets
(0.96)
Return On Equity
(13.58)
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.